Artist
I don't think KZA is lying regarding the PFS and OS. I think Garner did a nice job of in-licensing GDC 0084 from Genentech, leveraging his contacts from previous employers. Now I believe is the time to bring a seasoned biotech executive who has experience in running trials, raising money, and can tell a story to larger investors. The problem is KZA probably can't afford to pay this person...unless generous options are given.
- Forums
- ASX - By Stock
- KZA
- Extreme Chronic Undervalue
Extreme Chronic Undervalue, page-49
-
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online